|
1
|
Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients.
|
Clin Immunol
|
2011
|
2.78
|
|
2
|
Circulating tumour-derived microvesicles in plasma of gastric cancer patients.
|
Cancer Immunol Immunother
|
2009
|
1.55
|
|
3
|
Antitumor response of CD14+/CD16+ monocyte subpopulation.
|
Exp Hematol
|
2004
|
1.05
|
|
4
|
Tumor cell-induced deactivation of human monocytes.
|
J Leukoc Biol
|
2003
|
0.96
|
|
5
|
Human monocytes both enhance and inhibit the growth of human pancreatic cancer in SCID mice.
|
Anticancer Res
|
2008
|
0.92
|
|
6
|
Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells.
|
Anticancer Res
|
2012
|
0.82
|
|
7
|
Circulating CXCR4-positive stem/progenitor cells compete for SDF-1-positive niches in bone marrow, muscle and neural tissues: an alternative hypothesis to stem cell plasticity.
|
Folia Histochem Cytobiol
|
2003
|
0.82
|
|
8
|
Modulation of monocyte-tumour cell interactions by Mycobacterium vaccae.
|
Cancer Immunol Immunother
|
2004
|
0.80
|
|
9
|
Interactions of monocyte subpopulations generated from cord blood CD34(+) hematopoietic progenitors with tumor cells: assessment of antitumor potential.
|
Exp Hematol
|
2012
|
0.78
|